← Browse by Condition
Medical Condition

heterozygous familial hypercholesterolemia hefh

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3
NCT07058077 Phase 2, Phase 3
Recruiting

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

Enrollment
153 pts
Location
United States, Austr...
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07470723
Recruiting

The ORIGIN-FH Study

Enrollment
70 pts
Location
United States
Sponsor
University of Wisconsin, Madis...
View Trial →